COL17A1 and bullous pemphigoid: Bullous pemphigoid (BP) is an autoimmune blistering disease caused by autoantibodies to collagen type 17 (<i>COL17A1</i>) and is a recognized immune-related adverse event in patients receiving immune checkpoint inhibitors (ICIs).